Variables on day of RRT | Incidence (n = 1847) | ICU mortality | P | OR (95% CI) |
---|---|---|---|---|
Serum creatinine (μmol/L) |  |  |  |  |
≤ 200 | 456 (24.7%) | 255 (55.9%) | (≤ 500 vs >500) |  |
>200-500 | 1064 (57.6%) | 609 (57.2%) | <0.0001 | Â |
>500 | 278 (15.1%) | 102 (36.7%) | Â | 2.27 (1.75-2.96) |
≤ 309 | 953 (51.6%) | 564 (59.2%) | <0.0001 |  |
>309 (50 data missing) | 848 (45.9%) | 404 (47.6%) | Â | 1.59 (1.32-1.92) |
Serum pH | Â | Â | Â | Â |
<7.2 | 397 (21.5%) | 294 (74.1%) | (<7.2 vs | Â |
7.2-7.35 | 675 (36.5%) | 385 (57.0%) | ≥ 7.2) <0.0001 |  |
>7.35 (28 data missing) | 747 (40.4%) | 299 (40.0%) | Â | 0.32 (0.25-0.42) |
Serum K + (mmol/L) | Â | Â | Â | Â |
≤ 6 | 1634 (88.5%) | 877 (53.7%) |  |  |
>6 (28 data missing) | 185 (10.0%) | 101 (54.6%) | 0.82 | 0.96 (0.71-1.31) |
Urine output | Â | Â | Â | Â |
<400 ml/24 hours | 994 (53.8%) | 595 (59.9%) | Â | Â |
≥ 400 ml/24 hours | 853 (46.2%) | 404 (47.4%) | <0.0001 | 1.66 (1.38-1.99) |
Serum HCO 3 (mmol/L) | Â | Â | Â | Â |
<10 | 50 (2.7%) | 37 (74%) | (<15 vs | Â |
10-14.9 | 146 (7.9%) | 103 (70.5%) | ≥ 15) |  |
≥ 15 (577 data missing) | 1074 (58.1%) | 565 (52.6%) | <0.0001 | 2.25 (1.62-3.14) |
Serum urea (mg/dL) | Â | Â | Â | Â |
≤ 27.1 mmol/L | 1186 (64.2%) | 641 (54.0%) | 1 |  |
>27.1 mmol/L | 661 (35.8%) | 358 (54.2%) | Â | Â |
(30 data missing) | Â | Â | Â | Â |
MAP (mmHg) | Â | Â | Â | Â |
≤ 65 | 1,116 (60.4%) | 718 (64.3%) |  |  |
>65 (28 data missing) | 703 (38.1%) | 260 (37.0%) | <0.0001 | 3.07 (2.53-3.74) |
SOFA CVS score | Â | Â | Â | Â |
0 | 270 (14.6%) | 73 (27%) | SOFA ≤ 2 |  |
1 | 206 (11.2%) | 77 (37.4%) | versus | Â |
2 | 494 (26.7%) | 253 (51.2%) | SOFA >2 | Â |
3 | 0 | - | Â | Â |
4 | 877 (47.5%) | 596 (67.96%) | <0.0001 | 2.98 (2.47-3.61) |
SOFA RESP score | Â | Â | Â | Â |
0 | 21 (1.1%) | 17 (80.95%) | Â | Â |
1 | 0 | - | Â | Â |
2 | 225 (12.2%) | 43 (19.1%) | Â | Â |
3 | 0 | - | Â | Â |
4 | 1601 (86%) | 939 (58.7%) | <0.0001 | 4.4 (3.23-5.98) |
SOFA NEURO score | Â | Â | Â | Â |
0 | 1352 (73.2%) | 686 (50.7%) | Â | Â |
1 | 68 (3.7%) | 30 (44.1%) | Â | Â |
2 | 109 (5.9%) | 59 (54.1%) | Â | Â |
3 | 145 (7.9%) | 88 (60.7%) | <0.0001 | 2.32 (1.79-3.01) |
4 | 173 (9.4%) | 136 (78.6%) | Â | Â |
SOFA COAG score | Â | Â | Â | Â |
0 | 739 (40%) | 368 (49.8%) | Â | Â |
1 | 597 (32.3%) | 331 (55.4%) | Â | Â |
2 | 511 (27.7%) | 300 (58.7%) | Â | Â |
3 | 0 | - | Â | Â |
4 | 0 | - | N/A | Â |
SOFA LIVER score | Â | Â | Â | Â |
0 | 1125 (60.9%) | 550 (48.9%) | Â | Â |
1 | 206 (11.2%) | 129 (62.6%) | Â | Â |
2 | 140 (7.6%) | 292 (15.8%) | Â | Â |
3 | 188 (64.4%) | 84 (60.0%) | Â | Â |
4 | 84 (4.5%) | 48 (57.1%) | 0.133 | 1.25 (0.94-1.66) |
Total SOFA score | Â | Â | Â | Â |
≤ 12 | 1149 (62.2%) | 517 (45.0%) |  |  |
>12 (21 data missing) | 677 (36.7%) | 465 (68.7%) | <0.0001 | 0.37 (0.31-0.46) |
Organ failure | Â | Â | Â | Â |
CVS failure | 689 (37.3%) | 446 (64.7%) | Â | Â |
No CVS failure | 1,158 (62.7%) | 553 (47.8%) | <0.0001 | 2.01 (1.65-2.44) |
RS failure | 964 (52.2%) | 615 (63.8%) | Â | Â |
No RS failure | 883 (47.8%) | 384 (43.5%) | <0.0001 | 2.29 (1.90-2.76) |
GI failure | 428 (23.2%) | 299 (69.9%) | <0.0001 | 2.38 (1.89-3.00) |
No GI failure | 1419 (76.8%) | 700 (49.3%) | Â | Â |
NEURO failure | 210 (11.4%) | 160 (76.2%) | <0.0001 | 3.04 (2.18-4.24) |
No NEURO failure | 1,637 (88.6%) | 839 (51.3%) | Â | Â |
HAEM failure | 180 (9.7%) | 118 (65.6%) | Â | Â |
No HAEM failure | 1,667 (90.3%) | 881 (52.8%) | 0.0012 | 1.70 (1.23-2.34) |
HEP failure | 104 (5.6%) | 80 (76.9%) | Â | Â |
No HEP failure | 1743 (94.4%) | 919 (52.7%) | <0.0001 | 2.99 (1.88-4.76) |
CVS + RS failure | 352 (19.1%) | 260 (73.9%) | Â | Â |
No CVS + no RS failure | 546 (29.6%) | 198 (36.3%) | <0.0001 | 4.97 (3.70-6.67) |
Total number of failed organs | Â | Â | Â | Â |
0 | 129 (6.98%) | 34 (26.4%) | Â | Â |
1 | 437 (23.7%) | 166 (38.0%) | Â | Â |
2 | 683 (37.0%) | 365 (53.4%) | Â | Â |
3 | 389 (21.1%) | 255 (65.6%) | Â | Â |
>3 | 209 (11.3%) | 179 (85.6%) | Â | Â |